Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of infectious diseases
3.2.1.2 Technological advancements in bloodstream infection testing
3.2.1.3 Development and adoption of point-of-care testing (POCT) devices
3.2.1.4 Increased awareness and focus on healthcare-associated infections (HAIs)
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limitations of the existing tests
3.2.2.2 High initial setup and ongoing maintenance costs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Competitive analysis of major market players
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Reagents & consumables
5.3 Instruments
Chapter 6 Market Estimates and Forecast, By Sample Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Whole blood
6.3 Blood culture
Chapter 7 Market Estimates and Forecast, By Technology, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 PCR
7.3 Mass spectroscopy
7.4 In situ hybridization
7.5 Other technologies
Chapter 8 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals & diagnostic centers
8.3 Academic & research institutes
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Becton, Dickinson and Company
10.3 Bio-Rad Laboratories, Inc.
10.4 bioMérieux SA
10.5 Bruker Corporation
10.6 Danaher Corporation
10.7 F. Hoffmann-La Roche Ltd.
10.8 Luminex Corporation
10.9 Siemens Healthineers AG
10.10 Thermo Fisher Scientific Inc.
